Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

DERMDERM
11 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in JOURNEY MED CORP

CITADEL ADVISORS LLC holds 82,149 shares of DERM (JOURNEY MED CORP), worth $581,615 as of 2026-Q2. This is a new position. DERM represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$581,615

Current Shares

82,149

Total Value Change

+$523,615

Total Shares Change

+71,388

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
82,149
-
$581,6150.0%$7.08
34
2026-Q1
Exited
0
-100.0%
$00.0%$7.81
0
2025-Q4
Increased
69,415
+382.4%
$535,1890.0%$7.62
39
2025-Q3
New
14,390
-
$102,4570.0%$7.10
33
2025-Q2
Exited
0
-100.0%
$00.0%$7.14
0
2025-Q1
Increased
49,259
+10.5%
$290,6280.0%$6.11
26
2024-Q4
New
44,568
-
$174,2610.0%$3.97
35
2024-Q1
Exited
0
-100.0%
$00.0%$3.68
0
2023-Q4
New
11,357
-
$65,4160.0%$5.76
32
2022-Q1
Exited
0
-100.0%
$00.0%$4.80
0
2021-Q4
New
10,761
-
$58,0000.0%$5.17
32

Other major holders of DERM: Cerity Partners LLC, WASATCH ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used